Targeted cloning of cytotoxic T cells specific for minor histocompatibility antigens restricted by HLA class I molecules of interest

Transplantation

Volumn 74, Issue 12, 2002, Pages 1773-1780

  Akatsuka, Yoshiki ^a   Kondo, Eisei ^a   Taji, Hirohumi ^a   Morishima, Yasuo ^a   Yazaki, Makoto ^b   Obata, Yuichi ^c   Kodera, Yoshihisa ^d   Riddell, Stanley R ^e   Takahashi, Toshitada ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLELE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CELL ISOLATION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; RETROVIRUS;

EID: 0037184879     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200212270-00023     Document Type: Article

References (30)

1. Goulmy E, Human minor histocompatibility antigens: New concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997; 157: 125.
2. Warren EH, Gavin M, Greenberg PD, et al. Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation. Curr Opin Hematol 1998; 5: 429.
3. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281.
4. Tseng LH, Lin MT, Hansen JA, et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 1999; 94: 2911.
5. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555.
6. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graftversus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068.
7. Riddell SR, Warren EH, Gavin MA, et al. Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones. Cancer J 2000; 6(suppl 3): S250.
8. Dolstra H, Fredrix H, Maas F, et al. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia. J Exp Med 1999; 189: 301.
9. Pierce RA, Field ED, den Haan JM, et al. Cutting edge: The HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol 1999; 163: 6360.
10. den Haan JM, Meadows LM, Wang W, et al. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. Science 1998; 279: 1054.
11. den Haan JMM, Sherman NE, Blokland E, et al. Identification of a graft-versus-host disease-associated human minor histocompatibility antigen. Science 1995; 268: 1476.
12. Meadows L, Wang W, den Haan JM, et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 1997; 6: 273.
13. Brickner AG, Warren EH, Caldwell JA, et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001; 193: 195.
14. Wang W, Meadows LR, den Haan JMM, et al. Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269: 1588.
15. Warren EW, Gavin MA, Simpson E, et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 2000; 164: 2807.
16. Warren EH, Greenberg PD, Riddell SR. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood 1998; 91: 2197.
17. Longmate J, York J, La Rosa C, et al. Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes. Immunogenetics 2001; 52: 165.
18. Lee TD, Zhao TM, Mickey R, et al. The polymorphisms of HLA antigens in the Chinese. Tissue Antigens 1988; 32: 188.
19. Kabilan L, Andersson G, Lolli F, et al. Detection ofintracellular expression and secretion of interferon-gamma at the single-cell level after activation of human T cells with tetanus toxoid in vitro. Eur J Immunol 1990; 20: 1085.
20. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997; 99: 1739.
21. + T cells based on cytokine secretion. Eur J Immunol 1999; 29: 4053.
22. Vogt MH, Goulmy E, Kloosterboer FM, et al. UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: Characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood 2000; 96: 3126.
23. Schultze L, Michalak S, Seamon MJ, et al. CD40-activated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 1997; 100: 2757.
24. Kinsella TM, Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 1996; 7: 1405.
25. Akatsuka Y, Goldberg TA, Kondo E, et al. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 2002; 59: 502.
26. Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 1990; 128: 189.
27. Goulmy E, Gratama JW, Blokland E, et al. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 1983; 302: 159.
28. Vanderlugt CL, Begolka WS, Neville KL, et al. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev 1998; 164: 63.
29. Rufer N, Wolpert E, Helg C, et al. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation 1998; 66: 910.
30. Remberger M, Aschan J, Lonnqvist B, et al. An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation. Eur J Haematol 2001; 66: 50.